Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts

Henry S. Friedman, Robert C. Castellino, Gertrude B. Elion, Stephen T. Keir, Peter J. Houghton, Stewart P. Johnson, Darell D. Bigner

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds